chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt received flu vac on 12/13/16. Pt states after the injection her upper arm was sore and she couldn't sleep on it for a few days. States she didn't/couldn't move her arm/shoulder and it has continued to get worse since. Came in to see doctor on 2/13/17 to report symptoms.
Approx. 5 minutes following vaccine administration the patient developed a transient loss of consciousness resulting in a fall causing a small abrasion to his left forehead.  The patient regained consciousness immediately.  He was alert and oriented.  No witnessed convulsions were reported.  He denied any further neurological symptoms.  He reported that he did eat breakfast.  He denied symptoms of anaphylaxis or severe allergy symptoms.   By this time, paramedics arrived and the his blood pressure (and orthostatics), pulse, blood sugar, pulse oximetry, EKG findings were all within normal limits.  He refused to be taken to the Emergency Room as well as treatment for the head abrasion.  There were no physical signs of fracture.  The patient ambulated out of the clinical without difficulty, accompanied by his girlfriend.  S/sx of concussion were discussed w/ patient and he or his family members are instructed to  call 911 should he development further syncope  or other neurological symptoms.
injection site sore with red rash ( 3in diameter) and warm to touch  Recommend cold compresses to site (10min on /10min off); NSAIDS and antihistamines if able to tolerate. Caller verbalizes understanding 4/27-f/u call made; no answer
Covid Vaccine PFIZER given  3/25/21 AND  4/16/21 . Patient admitted to Floor bed Covid Positive 8/29/2021
Tired; Starting from around 2:00 pm, I started having high fever, peaking at 102 (then I took some Tylenol pills).; felt very dizzy and weak, having headache and wanting to vomit (but didn't); felt very dizzy and weak, having headache and wanting to vomit (but didn't); wanting to vomit (but didn't).; I realized that my heart beat rate was very high, at around 120 per minute; also felt hard to breath for at least couple of hours; felt very dizzy and weak, having headache and wanting to vomit (but didn't); extremely hard to standup on my feet because of above symptoms; Everything was good on the day when I got the second vaccine shot, except for some pain on my left arm; This is a spontaneous report from a contactable consumer (patient). This 31-year-old non-pregnant female consumer was reported for herself that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0196, Expiry Date: not reported), via an unspecified route of administration, administered in left arm on 25Jun2021 at 15:15 (at the age of 31 years) as dose 2, single for covid-19 immunisation. The patient medical history included known allergy to Cephalosporin. Concomitant medications were not reported. The patient previously received first dose of bnt162b2 PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0187, Expiry Date: not reported), via an unspecified route of administration, administered in left arm on 04Jun2021 at 14:30 (at the age of 31 years) as dose 1, single for covid-19 immunisation. Facility type vaccine was pharmacy or drug store. No other vaccine given in four weeks. No other medications in two weeks. No Covid prior and post vaccination. It was reported that everything was good on the day when she got the second vaccine shot, except for some pain on her left arm on 25Jun2021. Things got much worse on the second day (26Jun2021) when she woke at around 11:00 am. She felt very dizzy and weak, had headache and wanting to vomit (but didn't). She realized that her heart beat rate was very high, at around 120 per minute. She also felt hard to breath for at least couple of hours and extremely hard to standup on her feet because of above symptoms. But at that time, there was no fever. Starting from around 2:00 pm, she started having high fever, peaking at 102 (then she took some Tylenol pills). During the whole day, her heart beat was around 120 and felt very dizzy. From the third day to fifth day, heart beat rate became normal but still felt dizzy, headache and tired with low fever. The patient underwent lab tests and procedures which included body temperature: 102 f on 26Jun2021. Therapeutic measures were taken as a result of all events. The outcome of all events was recovered in 2021.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a Registered Nurse via a company representative refers to her 19 years daughter. In June 2008 (specified date unknown) the patient was vaccinated with the third dose of GARDASIL (lot# unspecified) (dose, route and location unspecified). The first dose of GARDASIL (lot# unspecified) (dose, route and location unspecified) was vaccinated in 2007 (specified date unknown). The reporter did not have any information about the second dose of GARDASIL (lot# unspecified) (dose, route and location unspecified), but the reporter did confirm that the patient did receive the second dose of GARDASIL. On an unspecified date, the patient experienced "low blood pressure and abdominal pain" after receiving the third dose of GARDASIL. The patient has sought medical attention via saw the doctor. The outcome of the events was not provided. Additional information has been requested.
pt devel urticarial type rash w/lesions (10cm) which were pruritic & were distributed all over extremities, torso & head w/o a specific pattern;lesions devel over a 10min period & lasted 2hrs;rash resolved w/symptomatic tx;
6-7 loose full diapers daily for 1 week strong smelling abnormal color. She breast feeds so normally not foul smelling.
SWELLING IN UPPER ARM WITH REDDNESS AND ITCHY.  DR RECCOMMENDED REST AND ICE.  ARM IS IMPROVING AND SOME REDDNESS, SWELLING AND ITCHYNESS STILL PRESENT.
Moderna Covid-19 EUA  I had extreme pain  and swelling in my left arm, shoulder, chest, and back.  Could not raise my arm without more pain.  This lasted about 24 hrs.  Started subsiding after the 24 hrs. and was gone after 48hrs.
This case was reported by a pharmacist and described the occurrence of dizziness and nausea in a subject of unspecified age and gender who was vaccinated with ENGREIX B (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of ENGERIX B (.5 ml). At an unknown time after vaccination with ENGERIX B, the subject experienced dizziness and nausea. At the time of reporting the outcome of the events were unspecified. This is one of three cases reported by this pharmacist where all three subjects experienced the same events with same lot number provided, see cases A0809417A and A0809418A for more details. No further information was provided.
Patient general malaise unknown cause. Onsite EMS was called vitals BP 140/70 BG 140 HR 90. Patient Refused evaluation or care. Released againstmedical advise.
Employee describes onset of severe back, neck and arm pain (bilat) about 6 hours post administration of 2nd Rabavert vaccine on Thursday Nov. 1st. Did not take temperature, but felt hot and sweaty. Both arms from hands to elbows appeared reddened, without any rash, itching or hives. No Shortness of breath, swelling or difficulty breathing. Next day she went to work and had bad headache and photophobia. Continued to have back and arm muscular pain. Took ASA for pain. Symptoms were gone by Saturday night Nov 3rd. Did not seek medical treatment.
Received Pfizer as the second dose instead of Moderna; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received Pfizer as the second dose instead of Moderna) in a 21-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS141413) for COVID-19 vaccination.     The patient had no known allergies. The patient never had COVID positive test or diagnosis.  Previously administered products included for Drug use for unknown indication: Hepatitis A on 20-May-2022. Past adverse reactions to the above products included No adverse event with Hepatitis A. Family history included Drug allergy (family allergy to codeine) since an unknown date.    On 27-Jun-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jul-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received Pfizer as the second dose instead of Moderna). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received Pfizer as the second dose instead of Moderna) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The patient received first dose of the Moderna vaccine at one facility and was referred to another facility for the second dose, where the patient was given Pfizer as the second dose on 25-JUL-2022 (batch no. FT9142). The reporter contacted medical doctor for opinion. No treatment medications were reported.
Pt recvd hep B vax 19DEC89, 29JAN90, & 02JUL90.Test results 20SEP90 were neg for HBSAB.Addt'l dose given;later test results pos for HBSAB.
She began to have an itchy throat and realized that she was having difficulty swallowing. She felt flushed and a bit warm. She went to an urgent care/emergency facility. Upon arrival, her temperature and blood pressure were slightly elevated. Provider gave Solu-Medrol, famotidine and diphenhydramine IV. She was released at 7:15pm feeling much better. She was given 3 rxs which were filled on 10/9/2015 for Medrol dosepak, famotidine and diphenhydramine.
- Reddish bumps (rash) around area of administration, appeared 3 days after (10/17/11) according to mother - hardly visible. - mother felt no treatment necessary - dr was informed 10/18/11.
while chewing the right corner on my lip was tingly; numbness on the right corner of my lip.; drooled out of right side of mouth; pain around right arm; small headache; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (while chewing the right corner on my lip was tingly), HYPOAESTHESIA ORAL (numbness on the right corner of my lip.), DROOLING (drooled out of right side of mouth), PAIN IN EXTREMITY (pain around right arm) and HEADACHE (small headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN, AMLODIPINE BESILATE (NORVASC), SIMVASTATIN (ZOCOR), GLICLAZIDE (MICROZIDE [GLICLAZIDE]), SITAGLIPTIN PHOSPHATE (JANUVIA), INSULIN GLARGINE (LANTUS), DOXEPIN, TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA), FLUTICASONE PROPIONATE (FLOVENT) and SALBUTAMOL SULFATE (VENTOLIN ACCUHALER) for an unknown indication.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced PARAESTHESIA ORAL (while chewing the right corner on my lip was tingly), HYPOAESTHESIA ORAL (numbness on the right corner of my lip.), DROOLING (drooled out of right side of mouth), PAIN IN EXTREMITY (pain around right arm) and HEADACHE (small headache). At the time of the report, PARAESTHESIA ORAL (while chewing the right corner on my lip was tingly), HYPOAESTHESIA ORAL (numbness on the right corner of my lip.), DROOLING (drooled out of right side of mouth), PAIN IN EXTREMITY (pain around right arm) and HEADACHE (small headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (worse reaction after getting the 1st booster dose), PYREXIA (after the 1st booster dose, she had fever for 1 day) and ACCIDENTAL OVERDOSE (full dose for the booster dose in a non immunocompromised patient) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 039K20-2A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: INFLUENZA VACCINE (annually). Past adverse reactions to the above products included No adverse event with INFLUENZA VACCINE. Concurrent medical conditions included Blood pressure high (concomitant, but controlled with a lot of medications).   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In September 2021, the patient experienced VACCINATION COMPLICATION (worse reaction after getting the 1st booster dose) and PYREXIA (after the 1st booster dose, she had fever for 1 day). On 26-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL OVERDOSE (full dose for the booster dose in a non immunocompromised patient). In September 2021, PYREXIA (after the 1st booster dose, she had fever for 1 day) had resolved. At the time of the report, VACCINATION COMPLICATION (worse reaction after getting the 1st booster dose) and ACCIDENTAL OVERDOSE (full dose for the booster dose in a non immunocompromised patient) outcome was unknown.            Patient had concomitant high blood pressure but controlled with a lot of concomitant medications. It was reported that patient had the annual flu vaccine but does not remember exact date of administration. Patient did not have Covid-19 prior to or after the getting the vaccines. No information on treatment medications was reported.   This case was linked to MOD-2022-533361, MOD-2022-533519 (Patient Link).
mixed vaccine of Pfizer and Moderna was administered to a patient; This spontaneous case was reported by a pharmacist and describes the occurrence of OFF LABEL USE (mixed vaccine of Pfizer and Moderna was administered to a patient) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Sep-2021, the patient experienced OFF LABEL USE (mixed vaccine of Pfizer and Moderna was administered to a patient). On 04-Sep-2021, OFF LABEL USE (mixed vaccine of Pfizer and Moderna was administered to a patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product was provided by the reporter. No treatment medication was provided.
Fever of 99.6; Chills; Right arm pain at the injection site; Nausea; A spontaneous report, was received from a healthcare professional (patient), a 62 year old female patient, unknown race and ethnicity, who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced nausea, fever of 99.6 (pyrexia), chills, and right arm pain at the injection site (injection site pain).  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 30 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot# 011J20A), intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 30 Dec 2020, after administration of the vaccine, the patient developed nausea, fever of 99.6 with chills, and right arm pain at the injection site. No treatment information was provided.   Action taken with first dose of mRNA-1273 in response to the events was not reported.   The outcome of the events, nausea, fever of 99.6, chills, and right arm pain at the injection site, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt stated that her throat felt like she had a ping and a zinger feeling (perhaps nerve evolvement?) on her neck and felt that the "quality" of her breathing was not "good."  Pt also stated that she felt a bit dizzy/lightheaded. Pt was kept for 30 minutes as a precaution and her vitals were taken: BP 128/80; HR 94; O2 100%. Pt verbalized feeling well enough to leave after the 30-minute observation period, although she was cautioned to seek IMMEDIATE medical attention (call 911)  if symptoms worsened or she was at all concerned. Pt verbalized understanding.   Pt did also state that she had similar symptoms after her first COVID-19 vaccination, although she did not report this information until the observation period after the shot this time.  Pt was also recommended to create her own VAERS report for this vaccination event and shown where on the pt handout paperwork the contact information for the VAERS is located; pt verbalized intent to do so.
very strong breast pains.   spoke to my gyno. Dr. about and she stated it was normal after the vaccine.  Pectoral Lymph node swelling.
After the vaccine I had fatigue, body ache, it went away after 24 hours. I got COVID 19 one month after, I called the doctor and the doctor gave me antibodies infusion, no fever, I was very tired the first day of COVID 19, I had symptoms for several days before I tested positive.
The 11th day after receiving the Moderna booster, I woke up with hives all over my body and extreme itchiness. The hives still continue every day to this day.
a 17-year-old received an adult dose of Havrix.; a 17-year-old received an adult dose of Havrix.; This case was reported by a nurse via call center representative and described the occurrence of overdose in a 17-year-old female patient who received HAV (Havrix adult) for prophylaxis.   On an unknown date, the patient received Havrix adult. On an unknown date, unknown after receiving Havrix adult, the patient experienced overdose and inappropriate age at vaccine administration. On an unknown date, the outcome of the overdose and inappropriate age at vaccine administration were unknown.   Additional Information: GSK Receipt Date: 30-MAR-2022 Reporter's Comments: Nurse reported that a 17 year old patient received an adult dose of Havrix.  The reporter consented to follow up. Additional Supportive Information: A 17 year old patient received an adult dose of Havrix, which led to overdose and inappropriate age at vaccine administration.
The Medical assistant gave the patient a DTAP (4-6 years) instead of a TDAP (18 and up) so patient will need to come back into the office to get this redone correctly. He will end up with a sore arm but no adverse reactions from this shot other than that. But it does put the patient at a disadvantage as he will need to come back into the office.
Suspected Vaccination Failure; shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 year after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient himself/ herself. The age at vaccination was not reported. The patient had shingles one year after receiving shingles vaccine. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule and laboratory test confirming shingles were unknown at the time of reporting
Patient came into the pharmacy today and showed me her arm. There was an obvious redness around the area the shot was given. It looked very much like someone who swells up quite a bit from bug bites. She said the rash itself is not painful, but that her arm/muscle is still painful from the vaccine. The rash was only slightly warm to the touch and she said her husband that that it had gone down since she woke up and noticed it yesterday (7/19/18). I recommended she try some hydrocortisone cream and oral BENADRYL and advised her that if it did not go down or continued to spread/get worse through today, she should go into the doctor.
Pregnant; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    No concomitant medications were reported. Patient's last menstrual period was not mentioned, and conception date was unknown. The patient's estimated due date is unknown.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.